UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine.
Comments Off on UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine.
April 27, 2026
Migraine is a primary headache disorder, which leads to diminished health-related quality of life (HRQoL). There is limited evidence assessing efficacy of ca...
Cannabis for MS Spasticity: A Systematic Review With Critically Unreliable Pooled Estimates
Comments Off on Cannabis for MS Spasticity: A Systematic Review With Critically Unreliable Pooled Estimates
March 25, 2026
Substantial heterogeneity (I² = 100% for overall and AS analyses; 91% for NRS) and asymmetry in funnel plots suggest possible publication bias and study variability.
medical cannabis evidence-based care: Phase 3 Trial Results
Comments Off on medical cannabis evidence-based care: Phase 3 Trial Results
March 3, 2026
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period with extensions up to one year. The study design follows rigorous…